Skip to content
OpenCapital
Get started

Dyne Therapeutics, Inc. DYN Market capitalization

Market capitalization at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.4B+159%
Arrowhead Research logo
Arrowhead ResearchARWR
$8.78B+402%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$3.38B+61.3%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.64B+40.3%
Scholar Rock logo
Scholar RockSRRK
$5.65B+85.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$3.02B+2.7%

Other financials

Income statement

See full
Operating income-$125.3M-2.4%
Net income-$120.9M-4.8%
EPS (diluted)-$0.73+30.5%

Balance sheet

See full
Cash & equivalents$753.1M+59.5%
Total debt$168.7M+623%
Total equity$865.1M+29.3%
Total assets$1.1B+49.8%

Cash flow

See full
Operating cash flow-$144.9M-36.9%
CapEx$221.0K-77.5%
Free cash flow-$145.1M-35.8%

Valuation

See full
Enterprise value$2.69B+228%

Returns & leverage

See full
Return on equity-58.9%-4.4pp
Debt / equity0.2×+0.2×
Current ratio19.9×-0.4×

Where this comes from

Computed from the period-end share price: $2.99B.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s market capitalization?
Dyne Therapeutics, Inc. (DYN) reported market capitalization of $2.99B in Q1 2026.
How has Dyne Therapeutics, Inc.'s market capitalization changed year-over-year?
Dyne Therapeutics, Inc.'s market capitalization increased by 152.9% year-over-year, from $1.18B to $2.99B.
What is the long-term trend for Dyne Therapeutics, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s market capitalization has grown at a 25.4% compound annual growth rate (CAGR), from $1.04B to $3.22B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.